Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection
WEST CHESTER, PA — In a significant development for Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), the company announced its lead dermatological product, YCANTHâ„¢, has been granted New Chemical Entity (NCE) Status …
Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection Read More